Cited by 40Mesenchymal stem cell researchHedgehog Signaling Pathway StudiesNeuroinflammation and Neurodegeneration Mechanisms

Multipotent Mesenchymal Stromal Cells Increase tPA Expression and Concomitantly Decrease PAI-1 Expression in Astrocytes through the Sonic Hedgehog Signaling Pathway after Stroke ( in vitro Study)

Open access
Xin, Hongqi, Li, Yi, Shen, Li Hong, Liu, Xianshuang, Hozeska-Solgot, Ann, Zhang, Rui Lan, Zhang, Zheng Gang, Chopp, Michael·2011·Journal of Cerebral Blood Flow & Metabolism

Abstract

Multipotent mesenchymal stromal cells (MSCs) increase tissue plasminogen activator (tPA) activity in astrocytes of the ischemic boundary zone, leading to increased neurite outgrowth in the brain. To probe the mechanisms that underlie MSC-mediated activation of tPA, we investigated the morphogenetic gene, sonic hedgehog (Shh) pathway. In vitro oxygen and glucose deprivation and coculture of astrocytes and MSCs were used to mimic an in vivo ischemic condition. Both real-time-PCR and western blot showed that MSC coculture significantly increased the Shh level and concomitantly increased tPA and decreased plasminogen activator inhibitor 1 (PAI-1) levels in astrocytes. Inhibiting the Shh signaling pathway with cyclopamine blocked the increase of tPA and the decrease of PAI-1 expression in astrocytes subjected to MSC coculture or recombinant mouse Shh (rm-Shh) treatment. Both MSCs and rm-Shh decreased the transforming growth factor- β1 level in astrocytes, and the Shh pathway inhibitor cyclopamine reversed these decreases. Both Shh-small-interfering RNA (siRNA) and Glil-siRNA downregulated Shh and Gli1 (a key mediator of the Shh transduction pathway) expression in cultured astrocytes and concomitantly decreased tPA expression and increased PAI-1 expression in these astrocytes after MSC or rm-Shh treatment. Our data indicate that MSCs increase astrocytic Shh, which subsequently increases tPA expression and decreases PAI-1 expression after ischemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/jcbfm.2011.116

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 40 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001b;32:1005–1011. doi: 10.1161/01.str.32.4.1005. [DOI] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Xin, H., Li, Y., Shen, L. H., Liu, X., Hozeska-Solgot, A., Zhang, R. L., Zhang, Z. G., & Chopp, M.
Affiliations
  • Henry Ford Health (US)
  • Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA
Corresponding author
Chopp, Michael
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2011-08-10
Volume
31
Issue
11
Pages
2181-2188
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W1972753549
Cited by
40
References
40
Citations by year
2024: 1 · 2023: 2 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 10 · 2012: 3
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R01AG037506)
  • National Institute of Neurological Disorders and Stroke (R01NS066041)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
multipotent mesenchymal stromal cells, tissue plasminogen activator, plasminogen activator inhibitor-1, Sonic hedgehog signaling, astrocytes, ischemic stroke, cyclopamine, Gli1, TGF-β1, oxygen-glucose deprivation, neurite outgrowth, co-culture
MeSH terms
Animals, Astrocytes, Culture Media, Glucose, Mice, Inbred C57BL, Oxygen, Tissue Plasminogen Activator, Signal Transduction, Down-Regulation, Cell Hypoxia, Up-Regulation, Coculture Techniques, Cell Culture Techniques, Receptor Cross-Talk, Stroke, Multipotent Stem Cells, Mice, Hedgehog Proteins, Serpin E2, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review